Device for Improving Heart Failure Symptoms
An implantable neuromodulation device was approved for symptom improvement in patients with advanced heart failure who aren ’t eligible for cardiac resynchronization therapy. Heart failure is the fourth leading cause of death attributable to cardiovascular disease, affecting 5.7 million people in the United States.
Source: JAMA - Category: General Medicine Source Type: research
More News: Brain | Cardiac Resynchronization Therapy | Cardiology | Cardiovascular | General Medicine | Heart | Heart Failure | Neurology | USA Health